Everand Logo

Welcome to Everand!

  • STAT

    Opinion: Star Wars and the U.S. health care system share this: bloat

    by Amit Phull Dec 23, 2019 4 minutes
    Source: George Brich/AP

    The final film in the epic Star Wars saga, “Star Wars: The Rise of Skywalker” hit theaters this weekend. It should have had fans around the world buzzing. Instead, many of them are either yawning with disinterest, or speculating on YouTube about just how bad the last installment in the 40-year-old series might be. The critics have panned the film in early reviews, with Rotten Tomatoes pegging the critical score at a meager 58%. What happened to Star Wars?

    As a doctor, movie lover, and proud tech geek, I often see parallels between work and my other hobbies.

    When I think about Star Wars, especially what has happened to the franchise after the Disney acquisition of Lucasfilm in 2013, some stark comparisons

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
    And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
    The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

    Related Books & Audiobooks